PharMerica CORP Net Income
PharMerica CORP reported Net Income of $3.20 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2017-11-09
- PharMerica CORP net income (loss) attributable to parent for the quarter ending 2017-09-30 was $3.20M, a 56.16% decline year-over-year.
- PharMerica CORP net income (loss) attributable to parent for the quarter ending 2017-06-30 was $4.70M, a 88.00% increase year-over-year.
- PharMerica CORP net income (loss) attributable to parent for the quarter ending 2017-03-31 was $3.50M, a 14.63% decline year-over-year.
- PharMerica CORP net income (loss) attributable to parent for the quarter ending 2016-12-31 was $7.70M, a 61.88% decline year-over-year.
- PharMerica CORP net income (loss) attributable to parent for fiscal 2016 was $21.60M, a 38.46% decline from fiscal 2015.
- PharMerica CORP net income (loss) attributable to parent for fiscal 2015 was $35.10M, a 416.18% increase from fiscal 2014.
- PharMerica CORP net income (loss) attributable to parent for fiscal 2014 was $6.80M, a 64.02% decline from fiscal 2013.
- PharMerica CORP net income (loss) attributable to parent for fiscal 2013 was $18.90M, a 17.47% decline from fiscal 2012.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-09-30 | $3.20M 10-Q · filed 2017-11-09 | $7.90M derived: sum of 2 quarters · filed 2017-11-09 | $11.40M 10-Q · filed 2017-11-09 | $19.10M derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | $4.70M 10-Q · filed 2017-08-02 | $8.20M 10-Q · filed 2017-08-02 | $15.90M derived: sum of 3 quarters · filed 2017-08-02 | $23.20M derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-03-31 | $3.50M 10-Q · filed 2017-05-10 | $11.20M derived: sum of 2 quarters · filed 2017-05-10 | $18.50M derived: sum of 3 quarters · filed 2017-11-09 | $21.00M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-12-31 | $7.70M 10-K · filed 2017-02-24 | $15.00M derived: sum of 2 quarters · filed 2017-11-09 | $17.50M derived: sum of 3 quarters · filed 2017-11-09 | $21.60M 10-K · filed 2017-02-24 |
| 2016-09-30 | $7.30M 10-Q · filed 2017-11-09 | $9.80M derived: sum of 2 quarters · filed 2017-11-09 | $13.90M 10-Q · filed 2017-11-09 | $34.10M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $2.50M 10-Q · filed 2017-08-02 | $6.60M 10-Q · filed 2017-08-02 | $26.80M derived: sum of 3 quarters · filed 2017-08-02 | $29.80M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | $4.10M 10-Q · filed 2017-05-10 | $24.30M derived: sum of 2 quarters · filed 2017-05-10 | $27.30M derived: sum of 3 quarters · filed 2017-05-10 | $29.60M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $20.20M 10-K · filed 2017-02-24 | $23.20M derived: sum of 2 quarters · filed 2017-02-24 | $25.50M derived: sum of 3 quarters · filed 2017-02-24 | $35.10M 10-K · filed 2017-02-24 |
| 2015-09-30 | $3.00M 10-K · filed 2017-02-24 | $5.30M derived: sum of 2 quarters · filed 2017-02-24 | $14.90M 10-Q · filed 2016-11-09 | $18.10M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $2.30M 10-K · filed 2017-02-24 | $11.90M 10-Q · filed 2016-08-09 | $15.10M derived: sum of 3 quarters · filed 2017-02-24 | $23.60M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $9.60M 10-K · filed 2017-02-24 | $12.80M derived: sum of 2 quarters · filed 2017-02-24 | $21.30M derived: sum of 3 quarters · filed 2017-02-24 | $11.60M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $3.20M 10-K · filed 2016-02-26 | $11.70M derived: sum of 2 quarters · filed 2016-02-26 | $2.00M derived: sum of 3 quarters · filed 2016-02-26 | $6.80M 10-K · filed 2017-02-24 |
| 2014-09-30 | $8.50M 10-K · filed 2016-02-26 | -$1.20M derived: sum of 2 quarters · filed 2016-02-26 | $3.60M 10-Q · filed 2015-11-06 | $8.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | -$9.70M 10-K · filed 2016-02-26 | -$4.90M 10-Q · filed 2015-08-07 | -$500.00K derived: sum of 3 quarters · filed 2016-02-26 | -$6.70M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $4.80M 10-K · filed 2016-02-26 | $9.20M derived: sum of 2 quarters · filed 2016-02-26 | $3.00M derived: sum of 3 quarters · filed 2016-02-26 | $13.20M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $4.40M 10-K · filed 2015-03-02 | -$1.80M derived: sum of 2 quarters · filed 2015-03-02 | $8.40M derived: sum of 3 quarters · filed 2015-03-02 | $18.90M 10-K · filed 2016-02-26 |
| 2013-09-30 | -$6.20M 10-K · filed 2015-03-02 | $4.00M derived: sum of 2 quarters · filed 2015-03-02 | $14.50M 10-Q · filed 2014-11-06 | $18.20M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $10.20M 10-K · filed 2015-03-02 | $20.70M 10-Q · filed 2014-08-05 | $24.40M derived: sum of 3 quarters · filed 2015-03-02 | $30.40M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $10.50M 10-K · filed 2015-03-02 | $14.20M derived: sum of 2 quarters · filed 2015-03-02 | $20.20M derived: sum of 3 quarters · filed 2015-03-02 | $27.80M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $3.70M 10-K · filed 2014-02-28 | $9.70M derived: sum of 2 quarters · filed 2014-02-28 | $17.30M derived: sum of 3 quarters · filed 2014-02-28 | $22.90M 10-K · filed 2015-03-02 |
| 2012-09-30 | $6.00M 10-Q · filed 2012-11-01 | $13.60M derived: sum of 2 quarters · filed 2014-02-28 | $19.20M 10-Q · filed 2013-11-05 | $27.10M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $7.60M 10-K · filed 2014-02-28 | $13.20M 10-Q · filed 2013-08-02 | $21.10M derived: sum of 3 quarters · filed 2014-02-28 | $25.90M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $5.60M 10-K · filed 2014-02-28 | $13.50M derived: sum of 2 quarters · filed 2014-02-28 | $18.30M derived: sum of 3 quarters · filed 2014-02-28 | $25.70M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $7.90M 10-K · filed 2013-02-07 | $12.70M derived: sum of 2 quarters · filed 2013-02-07 | $20.10M derived: sum of 3 quarters · filed 2013-02-07 | $23.40M 10-K · filed 2014-02-28 |
| 2011-09-30 | $4.80M 10-K · filed 2013-02-07 | $12.20M derived: sum of 2 quarters · filed 2013-02-07 | $15.50M 10-Q · filed 2012-11-01 | $20.20M derived: sum of 4 quarters · filed 2013-02-07 |
| 2011-06-30 | $7.40M 10-K · filed 2013-02-07 | $10.70M 10-Q · filed 2012-08-02 | $15.40M derived: sum of 3 quarters · filed 2013-02-07 | $20.20M derived: sum of 4 quarters · filed 2013-02-07 |
| 2011-03-31 | $3.30M 10-K · filed 2013-02-07 | $8.00M derived: sum of 2 quarters · filed 2013-02-07 | $12.80M derived: sum of 3 quarters · filed 2013-02-07 | $14.10M derived: sum of 4 quarters · filed 2013-02-07 |
| 2010-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-07 | $9.50M derived: sum of 2 quarters · filed 2013-02-07 | $10.80M derived: sum of 3 quarters · filed 2013-02-07 | $19.20M 10-K · filed 2013-02-07 |
| 2010-09-30 | $4.80M 10-Q · filed 2011-11-03 | $6.10M derived: sum of 2 quarters · filed 2011-11-03 | $14.50M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $1.30M 10-Q · filed 2011-08-04 | $9.70M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | $42.20M 10-K · filed 2012-02-09 |